Experimental and Molecular Medicine

Korean Society for Biochemistry and Molecular Biongy (생화학분자생물학회)
권호 표지

Growth promotion of HepG2 hepatoma cells by antisensemediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling

Sung, Young-Kwan;Hwang, Sun-Young;Farooq, Mohammad;Kim, Jung-Chul;Kim, Moon-Kyu

  • Published : 2003.08.31
⟨ Previous Next ⟩

Abstract

Glypican-3 (GPC3) encodes a cell-surface heparan-sulfate proteoglycan and its expression is frequently silenced in ovarian cancer, mesotheliomas, and breast cancer cell lines and ectopic expression of GPC3 inhibited the growth of these cells, suggesting that GPC3 plays a negative role in cell proliferation. In contrast, up-regulation of GPC3 is often observed in hepatoma, neuroblastoma, and Wilms' tumor. Whether GPC3 plays the same growth inhibitory role in these tumors remains to be studied. Here we report that antisense-mediated knockdown of GPC3 in the HepG2 hepatoma cells significantly promotes the growth of hepatoma cells. In addition, we show that this growth promotion is independent of insulin-like growth factor 2 (IGF2) signaling. Our data suggest that GPC3 plays a growth-suppressing role in hepatoma and provide cell biological evidence inconsistent with the hypothesis that GPC3 acts as a growth suppressor by downregulating IGF2.

Keywords

References

  1. J. Cell Biol. v.146 Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome Cano-Gauci, D.F.;Song, H.H.;Yang, H.;McKerlie, C.;Choo, B.;Shi, W.;Pullano, R.;Piscione, T.D.;Grisaru, S.;Soon, S.;Sedlackova, L.;Tanswell, A.K.;Mar, T.W.;Yeger, H.;Lockwood, G.A.;Rosenblum, N.D.;Filmus, J.
  2. Dev Biol. v.243 Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling Chiao, E.;Fisher, P.;Crisponi, L.;Deiana, M.;Dragatsis, I.;Schlessinger, D.;Pilia, G.;Efstratiadis, A.
  3. Exp. Mol. Med. v.34 HPV E6 antisense induces apoptosis in CaSki cells via suppression of E6 splicing Cho, C.W.;Poo, H.;Cho, Y.S.;Cho, M.C.;Lee, A.K.;Lee, S.J.;Park, S.N.;Kim, I.K.;Jung, Y.K.;Choe, Y.K.;Yeom, Y.I.;Choe, I.S.;Yoon, D.Y.
  4. Genes Dev. v.11 Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes Eggenschwiler, J.;Ludwig, T.;Fisher, P.;Leighton, P.A.;Tilghman, S.M.;Efstratiadis, A.
  5. J. Cell. Biol. v.141 OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner Gonzalez, A.D.;Kaya, M.;Shi, W.;Song, H.;Testa, J.R.;Penn, L.Z.;Filmus, J.
  6. Dev Biol. v.231 Glypican-3 modulates BMP-and FGF-mediated effects during renal branching morphogenesis Grisaru, S.;Cano-Gauci, D.;Tee, J.;Filmus, J.;Rosenblum, N.D.
  7. Cancer Res. v.57 Cloning and expression of a developmentally regulated transcript MXR6 in hepatocellular carcinoma: blological significance and temporospatial distribution Hsu, H.C.;Cheng, W.;Lai, P.L.
  8. Am J. Med Genet v.11 Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families Hughes-Benzie, R.M.;Pilia, G.;Xuan, J.Y.;Hunter, A.G.;Chen, E.;Golabi, M.;Hurst, J.A.;Kobori, J.;Marymee, K.;Pagon, R.A.;Punnett, H.H.;Schelley, S.;Tolmie, J.L.;Wohlferd, M.M.;Grossman, T.;Schlessinger, D.;Mackenzie, A.E.
  9. Cancer Res v.59 Frequent silencing of the GPC3 gene in ovarian cancer cell lines Lin, H.;Huber, R.;Schlessinger, D.;Morin, P.J.
  10. Biochem J. v.327 Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor Mast, A.E.;Higuchi, D.A.;Huang, Z.F.;Warshawsky, I.;Schwartz, A.L.Broze, G.J. Jr.
  11. Int. J. Cancer v.103 Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling Midorikawa, Y.;Ishikawa, S.;Iwanari, H.;Imamura, T.;Sakamoto, H.;Miyazono, K.;Kodama, T.;Makuuchi, M.;Aburatani, H.
  12. Oncogene v.19 Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma Murthy, S.S.;Shen, T.;De Rienzo, A.;Lee, W.C.;Ferriola, P.C.;Jhanwar, S.C.;Mossman, B.T.;Filmus, J.;Testa, J.R.
  13. Dev Biol. v.225 glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development Paine-Saunders, S.;Biviano,B.L.;Zupicich,J.;Skarnes,W.C.;Saunders,S.
  14. Int. J. Cancer v.62 Characterization of cell lines established from human hepatocellular carcinoma Park, J.G.;Lee, J.H.;Kang, M.S.;Park, K.J.;Jeon, Y.M.;Lee, H.J.;Kwon, H.S.;Park, H.S.;Yeo, K.S.;Lee, K.U.;Kim, S.T.;Chung, J.K.;Hwang, Y.J.;Lee, H.S.;Kim, C.Y.;Lee, Y.I.;Chen, T.R.;Hay, R.J.;Song, S.Y.;Kim, W.H.;Kim, C.W.;Kim, Y.I.
  15. Nat Genet v.12 Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome Pilia, G.;Hughes-Benzie R.M.;Mackenzie, A.;Baybayan, P.;Chen, E.Y.;Huber, R.;Neri, G.;Cao, A.;Forabosco, A.;Schles-singer, D.
  16. Int. J. Cancer v.89 Expression of glypican 3 (GPC3) in embryonal tumors Saikali, Z.;Sinnett, D.
  17. Exp. Mol. Med. v.34 Human hepatocellular carcinoma cells resist t TRAIL-induced apoptosis, and the resistance is abolished by cisplatin Shin, E.C.;Seong, Y.R.;Kim, C.H.;Kim, H.;Ahn, Y.S.;Kim, K.;Kim, S.J.;Hong, S.S.;Park, J.H.
  18. J. Biol. Chem. v.272 OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2 Song, H.H.;Shi, W.;Filmus, J.
  19. J. Biol. Chem. v.277 a member of the secretory gland protein family, is up-regulated in nasal respiratory epithelium after olfactory bulvectomy Sung, Y.K.;Moon, C.;Yoo, J.Y.;Moon, C.;Pearse, D.;Revsner, J.;Ronnett, G.V.;Plunc
  20. Cancer Sci. v.94 Glypican-3 is overexpressed in human hepatocellular carcinoma Sung, Y,K.;Hwang, S.Y.;Park, M.K.;Faroq, M.;Han, I.S.;Bae, H.I.;Kim, J.C.;Kim, M.K.
  21. J. Pediatr hematol Oncol v.23 Glypican-3 expression in Wilms tumor and hepatoblastoma Toretsky, J.A.;Zitomersky, N.L.;Eskenazi, A.E.;Voigt, R.W.;Strauch, E.D.;Sun, C.C.;Huber, R.;Meltzer, S.J.;Schlessinger, D.
  22. Oncogene v.20 Glypican-3 expression is silenced in human breast cancer Xiang, Y.Y.;Ladeda, V.;Filmus, J.
  23. J. Clin Endocrinol Metab v.83 Developmental regulation of the soluble form of insulin-like growth factorll/mannose 6-phosphate receptor in human serum and amniotic fluid Xu, Y.;Papageorgiou, A.;Polychronakos, C.
  24. Gut. v.48 Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders Zhu, Z.W.;Friess, H.;Wang, L.;Abou-Shady, M.;Zimmermann, A.;Lander, A.D.;Korc, M.;Kleeff, J.;Buchler, M.W.